A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1Since this is a Phase 1 trial primarily measuring safety — like adverse events, vital signs, and ECG changes — rather than whether BBT002 actually improves my COPD symptoms, is it worth discussing whether my current stage of COPD is better served by an established treatment first?
2. 2The trial includes both healthy volunteers and people with COPD, so how does my doctor think the safety profile seen in healthy volunteers so far might or might not translate to someone with my lung condition?
3. 3Because this study involves both single and multiple doses of a brand-new drug called BBT002, what kinds of adverse events or changes to my heart rhythm or lab results would my doctor want me to watch out for if I were to participate?
4. 4This trial also enrolls people with chronic rhinosinusitis with nasal polyps — does my doctor think there's anything about that broader eligibility that could affect what we learn about COPD specifically, and how that might matter for me?
5. 5Given that BBT002 is still in Phase 1 and the trial is actively recruiting, what does my doctor think about the timing — would waiting for Phase 2 or Phase 3 results give us more information about effectiveness before making a decision?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.